Conversation with The Cancer LetterFree St. Jude’s Roberts: “No single institution can maximize cures and minimize toxicities alone” March 08, 2019Vol.45 No.10By Matthew Bin Han Ong
Conversation with The Cancer LetterFree CHOP’s Resnick: Big data will transition from research to the standard of care in the clinic March 08, 2019Vol.45 No.10By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Sharpless: With $500 million, NCI can create data federation that would change research in childhood cancer March 08, 2019Vol.45 No.10By Matthew Bin Han Ong
Free Trump’s proposal for pediatric cancer has NCI envisioning the first data federation of its kind March 08, 2019Vol.45 No.10By Matthew Bin Han Ong
Free FDA tightens regulation of robotic devices in minimally invasive surgery for cancer March 01, 2019Vol.45 No.09By Matthew Bin Han Ong
Drugs & TargetsFree FDA approves therapy for adult patients with blood clotting disorder February 08, 2019Vol.45 No.06
Drugs & TargetsFree Pfizer given positive CHMP opinion for Vizimpro in NSCLC February 08, 2019Vol.45 No.06
Drugs & TargetsFree Genentech submits sBLA for Kadcyla for breast cancer February 08, 2019Vol.45 No.06
